Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...
Alexion, AstraZeneca Rare Disease in Deal with Pfizer
Morrison & Co and Brookfield’s A$3.7 Billion Acquisition of Uniti Group
Clayton Utz advised Uniti Group on the sale to Morrison & Co, Brookfield Asset Management and Commonwealth Superannuation Corporation, assisted by Allens. A consortium of Morrison...
OMERS Infrastructure Management’s A$950 Million Acquisition of Asia-Pacific Digital Infrastructure Asset
Allens advised TPG Telecom on the sale. OMERS Infrastructure was advised by RBC Capital Markets, Baker McKenzie, PricewaterhouseCoopers, Altman Solon, Grex Consulting and Alvarez & Marsal....
Wheels Up’s Acquisition of Air Partner
Arnold & Porter advised Wheels Up Experience Inc on the deal. Wheels Up Experience Inc announced its acquisition of London Stock Exchange-listed Air Partner plc. Wheels Up...
Touchlight’s Renegotiated License with AskBio and Joint Venture Exit
Arnold & Porter Kaye Scholer advised Touchlight on the deal. Biotechnology and CDMO company Touchlight (www.touchlight.com) announced its renegotiation with AskBio (www.askbio.com), a clinical stage adeno-associated virus...
Better HoldCo’s Acquisition of Trussle
Arnold & Porter Kaye Scholer advised Better HoldCo Inc. on the deal. Better HoldCo, Inc., one of the fastest-growing digital homeownership platforms in the U.S., announced its...
Morrison & Co and Future Fund Consortium’s $2.8 Billion Investment in InfraCo Towers
Allens acted for Morrison & Co and the consortium led by the Future Fund Board of Guardians and including Commonwealth Superannuation Corporation and Sunsuper Superannuation Fund...